825 related articles for article (PubMed ID: 8579962)
41. Long-term treatment of lasofoxifene preserves bone mass and bone strength and does not adversely affect the uterus in ovariectomized rats.
Ke HZ; Foley GL; Simmons HA; Shen V; Thompson DD
Endocrinology; 2004 Apr; 145(4):1996-2005. PubMed ID: 14726439
[TBL] [Abstract][Full Text] [Related]
42. Effects of prostaglandin E2 and F2 alpha on the skeleton of osteopenic ovariectomized rats.
Ma YF; Li XJ; Jee WS; McOsker J; Liang XG; Setterberg R; Chow SY
Bone; 1995 Dec; 17(6):549-54. PubMed ID: 8835309
[TBL] [Abstract][Full Text] [Related]
43. Bipedal stance exercise enhances antiresorption effects of estrogen and counteracts its inhibitory effect on bone formation in sham and ovariectomized rats.
Chen JL; Yao W; Frost HM; Li CY; Setterberg RB; Jee WS
Bone; 2001 Aug; 29(2):126-33. PubMed ID: 11502473
[TBL] [Abstract][Full Text] [Related]
44. Increased bone resorption precedes increased bone formation in the ovariectomized rat.
Sims NA; Morris HA; Moore RJ; Durbridge TC
Calcif Tissue Int; 1996 Aug; 59(2):121-7. PubMed ID: 8687981
[TBL] [Abstract][Full Text] [Related]
45. Effects of separate and combined therapy with growth hormone and parathyroid hormone on lumbar vertebral bone in aged ovariectomized osteopenic rats.
Wang L; Orhii PB; Banu J; Kalu DN
Bone; 2001 Feb; 28(2):202-7. PubMed ID: 11182379
[TBL] [Abstract][Full Text] [Related]
46. Lycopene treatment against loss of bone mass, microarchitecture and strength in relation to regulatory mechanisms in a postmenopausal osteoporosis model.
Ardawi MM; Badawoud MH; Hassan SM; Rouzi AA; Ardawi JMS; AlNosani NM; Qari MH; Mousa SA
Bone; 2016 Feb; 83():127-140. PubMed ID: 26549245
[TBL] [Abstract][Full Text] [Related]
47. Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid.
Glatt M; Pataki A; Evans GP; Hornby SB; Green JR
Osteoporos Int; 2004 Sep; 15(9):707-15. PubMed ID: 15024556
[TBL] [Abstract][Full Text] [Related]
48. Comparative effects of long-term continuous release of 16 alpha-hydroxyestrone and 17 beta-estradiol on bone, uterus, and serum cholesterol in ovariectomized adult rats.
Lotinun S; Westerlind KC; Kennedy AM; Turner RT
Bone; 2003 Jul; 33(1):124-31. PubMed ID: 12919707
[TBL] [Abstract][Full Text] [Related]
49. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
50. [Correlative changes of histomorphometry and biomechanical property of lumbar vertebrae body in ovariectomized rats].
Cui L; Chen H; Xu B; Liu Y; Wu T; Chen M; Li L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Apr; 21(2):178-83. PubMed ID: 15143534
[TBL] [Abstract][Full Text] [Related]
51. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
Zhou H; Shen V; Dempster DW; Lindsay R
J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
[TBL] [Abstract][Full Text] [Related]
52. Growth hormone increases vertebral and femoral bone strength in osteopenic, ovariectomized, aged rats in a dose-dependent and site-specific manner.
Mosekilde L; Thomsen JS; Orhii PB; Kalu DN
Bone; 1998 Oct; 23(4):343-52. PubMed ID: 9763146
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of substance P signaling aggravates the bone loss in ovariectomy-induced osteoporosis.
Zheng XF; Zhao ED; He JY; Zhang YH; Jiang SD; Jiang LS
Prog Biophys Mol Biol; 2016 Nov; 122(2):112-121. PubMed ID: 27237582
[TBL] [Abstract][Full Text] [Related]
54. Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia.
Ke HZ; Shen VW; Qi H; Crawford DT; Wu DD; Liang XG; Chidsey-Frink KL; Pirie CM; Simmons HA; Thompson DD
Bone; 1998 Sep; 23(3):249-55. PubMed ID: 9737347
[TBL] [Abstract][Full Text] [Related]
55. Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat.
Martel C; Picard S; Richard V; Bélanger A; Labrie C; Labrie F
J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):45-56. PubMed ID: 11074355
[TBL] [Abstract][Full Text] [Related]
56. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy.
Ke HZ; Jee WS; Zeng QQ; Li M; Lin BY
Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919
[TBL] [Abstract][Full Text] [Related]
57. Fast and long acting neoflavonoids dalbergin isolated from Dalbergia sissoo heartwood is osteoprotective in ovariectomized model of osteoporosis: Osteoprotective effect of Dalbergin.
Choudhary D; Kushwaha P; Gautam J; Kumar P; Verma A; Kumar A; Maurya SW; Siddiqui IR; Mishra PR; Maurya R; Trivedi R
Biomed Pharmacother; 2016 Oct; 83():942-957. PubMed ID: 27522257
[TBL] [Abstract][Full Text] [Related]
58. Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats.
Turner RT; Evans GL; Cavolina JM; Halloran B; Morey-Holton E
Endocrinology; 1998 Oct; 139(10):4086-91. PubMed ID: 9751486
[TBL] [Abstract][Full Text] [Related]
59. A comparison of the skeletal effects of intermittent and continuous administration of calcitonin in ovariectomized rats.
Li M; Shen Y; Burton KW; DeLuca PP; Mehta RC; Baumann BD; Wronski TJ
Bone; 1996 Apr; 18(4):375-80. PubMed ID: 8726397
[TBL] [Abstract][Full Text] [Related]
60. Protective effect of low-dose risedronate against osteocyte apoptosis and bone loss in ovariectomized rats.
Ye T; Cao P; Qi J; Zhou Q; Rao DS; Qiu S
PLoS One; 2017; 12(10):e0186012. PubMed ID: 29045447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
